Product Categories

• Biochemistry [24]
• Biotechnology [6]
• Chemistry [34]
• Consumables [48]
• Engineering [67]
• Environment [6]
• Haematology [2]
• Health [10]
• Health & Safety [35]
• Imaging [18]
• Lab Design & Storage [47]
• Lab Services [28]
• Microbiology [18]
• Pharma [13]
• Recruitment [1]
• Sample Preparation [42]
• Separation Techniques [17]
• Software [43]
• Spectroscopy [12]
• Test Equipment [11]

OTHER CATEGORIES

• Associations [24]

Laboratory News Directory is not responsible for the content of external internet sites

    

Breathalyser makes an easy diagnosis

Researchers are using state-of-the-art equipment to develop a breath test for diagnosing diseases including diabetes and cancer.

Dr Masood Yousef is a senior research assistant at Swansea University is using GCMS-TD (gas chromatography, mass spectrometry and thermal desorption) technology to analyse the concentrations of volatile organic compounds (VOCs) in breath.

Dr Yousef said: "Studies have shown that high concentrations of certain VOCs in breath can correlate with disease. For example, the odour of 'pear drops' esters and acetone in relation to diabetes, ammonia in relation to hepatitis, and dimethyl sulphide to cirrhosis. There are also certain compounds that seem to mark out particular types of cancer.

"If unique markers for specific diseases can be recognised earlier than traditional techniques, then there is immense potential to revolutionise early disease diagnosis before any symptoms have developed, and without the need for invasive procedures."

Diagnostic techniques based on exhaled breath are much less developed than traditional blood or urine analysis techniques, and are not widely utilised in clinical practice. Such techniques have also previously been seen as crude, subjective and unreliable.However, due to improved analytical methodology, volatile marker-based diagnostics offers new potential in the rapid diagnosis and monitoring of illnesses.

Dr Yousef believes that the breath test will provide a more convenient and rapid method for diagnosing serious diseases than blood or urine analysis, and will require minimal medical intervention.

He said: "Breath samples are much easier to collect than blood and urine, for the patient as much as for the person collecting the sample. They can be collected anywhere by people with no medical training, and there are no associated biohazard risks.

"Overall, the procedure is likely to be much more cost effective than conventional methods, potentially saving the NHS a great deal of time and money."

The GCMS-TD equipment has been funded by a grant from the Welsh Assembly Government Knowledge Exploitation Fund. It was originally used to research the level of solvents and other VOCs inhaled by operators of printing machinery.